Economy
Financial Markets
Commodities
Industries
Energy
Real Estate
Local listed Company
Overseas-listed Company
Foreign Company
Industrial Parks

 
Company - Domestic
 Search News  Or
Chase Sun Pharmaceutical's shares up 61.92% at debut on ChiNext

Oct. 30, 2009 (China Knowledge) - Tianjin Chase Sun Pharmaceutical Co Ltd<300026> debuted on the ChiNext Board on the Shenzhen Stock Exchange today, becoming one of the first companies to trade on the Nasdaq-style board.

Shares of the company opened at RMB 97.15, a price 61.92% higher than the IPO price, while the Shenzhen Component Index opened 1.92% higher at 12427.10 points.

The company raised RMB 123.89 million by issuing 12.59 million shares, or 25.01% of the company’s enlarged capital. Guodu Securities Co was the underwriter of the offering.

The Tianjin-based pharmaceutical company posted RMB 140.65 million of operating revenue in the third quarter of this year, with net profit standing at RMB 52.73 million. Its main product Xuebijing Injection is currently the only drug available for treating sepsis and multiple organ dysfunction syndrome in China







Copyright © "2013" www.chinaknowledge.com

Send feedback or comments to: news@chinaknowledge.com

For more news, financial weekly reports, business guides to China, Market Research Reports and other premium information, subscribe to China Knowledge today

To access our page on Bloomberg, type CKFI (GO)

 Our Professional Services
 News Archive
About Us | CSR | Media Center | E-Newsletter | E-Store | Contact Us | Feedback | Sitemap | Privacy Policy | Terms of Use  

           Copyright © 2014 China Knowledge Online. All Rights Reserved